Sanofi's Top-Selling Drug Just Snagged Another Approval From the FDA
- Oops!Something went wrong.Please try again later.
- Oops!Something went wrong.Please try again later.
- SNY
- REGN
Mega-blockbuster Dupixent was just given the FDA's green light to treat patients with a chronic, progressive inflammatory disease.